CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CIK 1187953
Ticker
CELZ (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Phoenix, AZ 85012
Fiscal year end
2025 (FY)
Market Data
Close
$0.84
Change
+$0.01
Change %
1.75%
Volume
1,048
CELZ · trading date Oct 12, 2026 · previous close $0.82 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$6.0K
Net income
-$6.00M
Total assets
$7.81M
Total liabilities
$284.9K
Stockholders' equity
$7.51M
Cash & equivalents
$7.21M
Operating income
-$6.14M
Operating cash flow
-$5.86M
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-03-20.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-102,380.2%
Net margin
-99,916.8%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
3.6%
Equity / assets
96.2%
CapEx / revenue
—
Operating cash flow / net income
0.98×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Phoenix, AZ 85012
211 E. OSBORN RD.
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:12 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.